US 10421963
Oligonucleotide therapy for leber congenital amaurosis
granted A61KA61K31/7125A61P
Quick answer
US patent 10421963 (Oligonucleotide therapy for leber congenital amaurosis) held by ProQR Therapeutics II B.V. expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ProQR Therapeutics II B.V.
- Grant date
- Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/7125, A61P, A61P27/02